Site search2022
- 2022.11.10PRBrightPath to Update the Pre-clinical Data of BP1210 and BP1212 at SITC 2022（218KB）
- 2022.11.10PRBrightPath to Update the Pre-clinical Data of BP1202 at SITC 2022（324KB）
- 2022.11.10PRBrightPath to Update the Pre-clinical Data of iPS-NKT at SITC 2022（216KB）
- 2022.11.1IRBrightPath Exercised the Option to Obtain Exclusive Development, Manufacturing and Marketing License for iPS-NKT from RIKEN（131KB）
- 2022.10.5PRBrightPath to Update the Pre-clinical Data of iPS-NKT, BP1202 and BP1212 at SITC 2022（321KB）
- 2022.5.12IRAnnouncement of the early termination of a phase II clinical trial of the cancer peptide vaccine GRN-1201 in the United States and Top-line data（254KB）
- 2022.5.12IRFinancial Results for the Fiscal Year ended March 31, 2022 [Japanese GAAP] (non-consolidated)（423KB）
- 2022.5.9IRPhase I clinical trial initiated for HER2-targeted CAR-T cell therapy BP2301 （225 KB）
- 2022.4.13PRBrightPath Presents Preclinical Data on a CD73 antagonist antibody at AACR 2022（214 KB）
- 2022.4.13PRBrightPath Presents New Data on Personalized Neoantigen Vaccine at AACR 2022（268KB）
- 2022.4.11PRBrightPath Presents New Data on Personalized Neoantigen Vaccine at AACR 2022（313KB）
- 2022.4.11PRBrightPath Presents New Data on Preclinical Data on BP2301(HER2 CAR-T) at AACR 2022（288KB）
- 2022.3.9PRBrightPath to Present Updates on the Preclinical Data of BP2301,BP1200,BP1209 at AACR 2022
- 2022.3.4PRBrightPath's neoantigen vaccine research published in Cancer Science
- 2022.11.1IRBrightPath Exercised the Option to Obtain Exclusive Development, Manufacturing and Marketing License for iPS-NKT from RIKEN（131KB）
- 2022.5.12IRAnnouncement of the early termination of a phase II clinical trial of the cancer peptide vaccine GRN-1201 in the United States and Top-line data（254KB）
- 2022.5.12IRFinancial Results for the Fiscal Year ended March 31, 2022 [Japanese GAAP] (non-consolidated)（423KB）
- 2022.5.9IRPhase I clinical trial initiated for HER2-targeted CAR-T cell therapy BP2301 （225 KB）
- 2022.11.10PRBrightPath to Update the Pre-clinical Data of BP1210 and BP1212 at SITC 2022（218KB）
- 2022.11.10PRBrightPath to Update the Pre-clinical Data of BP1202 at SITC 2022（324KB）
- 2022.11.10PRBrightPath to Update the Pre-clinical Data of iPS-NKT at SITC 2022（216KB）
- 2022.10.5PRBrightPath to Update the Pre-clinical Data of iPS-NKT, BP1202 and BP1212 at SITC 2022（321KB）
- 2022.4.13PRBrightPath Presents Preclinical Data on a CD73 antagonist antibody at AACR 2022（214 KB）
- 2022.4.13PRBrightPath Presents New Data on Personalized Neoantigen Vaccine at AACR 2022（268KB）
- 2022.4.11PRBrightPath Presents New Data on Personalized Neoantigen Vaccine at AACR 2022（313KB）
- 2022.4.11PRBrightPath Presents New Data on Preclinical Data on BP2301(HER2 CAR-T) at AACR 2022（288KB）
- 2022.3.9PRBrightPath to Present Updates on the Preclinical Data of BP2301,BP1200,BP1209 at AACR 2022
- 2022.3.4PRBrightPath's neoantigen vaccine research published in Cancer Science